Detected ·
MyoPax
——
Berlin biotech MyoPax, a Charité/Max Delbrück Center spin-off developing a muscle stem cell + CRISPR gene-repair therapy platform, has received funding from IBB Ventures' new B# Plus fund, complementing EIC Accelerator support.
- Website
- myopax.com
- linkedin.com/company/86304529
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-13 08:02:17 UTC
- Signal ID
- 1c415faa-21ed-4c1b-8120-17f8ba657040
As the API returns it
{
"id": "1c415faa-21ed-4c1b-8120-17f8ba657040",
"created_at": "2026-10-13T08:02:17.214274Z",
"company_name": "MyoPax",
"company_website_url": "myopax.com",
"company_linkedin_url": "https://www.linkedin.com/company/86304529",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Berlin biotech MyoPax, a Charité/Max Delbrück Center spin-off developing a muscle stem cell + CRISPR gene-repair therapy platform, has received funding from IBB Ventures' new B# Plus fund, complementing EIC Accelerator support.*"
}